Tejedor-Alonso MA1,2, Moro-Moro M1, Múgica-García MV3
| ||||
1Allergy Unit, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain
2Medicine and Surgery Department, Universidad Rey Juan Carlos, Alcorcón, Spain 3Allergy Service, Hospital Universitario de la Princesa, Madrid, Spain | ||||
J Investig Allergol Clin Immunol 2015; Vol. 25(3): 163-175
| ||||
|
A blog that publishes updates and open access scientific papers about allergy, asthma and immunology. Editor: Juan Carlos Ivancevich, MD. Specialist in Allergy & Immunology
June 17, 2015
Epidemiology of Anaphylaxis: Contributions From the Last 10 Years
Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study
Ming Zeng, Zhi-Yong Li, Jin Ma, Ping-Ping Cao, Heng Wang, Yong-Hua Cui and Zheng Liu*
Abstract
Background
Phenotype of chronic rhinosinusitis (CRS) may be an important determining factor of the efficacy of anti-inflammatory treatments. Although both glucocorticoids and macrolide antibiotics have been recommended for the treatment of CRS, whether they have different anti-inflammatory functions for distinct phenotypic CRS has not been completely understood. The aim of this study is to compare the anti-inflammatory effects of clarithromycin and dexamethasone on sinonasal mucosal explants from different phenotypic CRS ex vivo.
Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
Research
Amanda L. McDonell1*, Ulrich Wahn2, Dirk Demuth1, Catrina Richards1, Charlie Hawes3, Jakob Nørgaard Andreasen4and Felicia Allen-Ramey5
Abstract (provisional)
Background Allergy immunotherapy is an effective treatment for patients with allergic rhinitis whose symptoms are unresolved with pharmacotherapy. Allergy immunotherapy for grass pollen-induced allergic rhinitis is available in three modalities: subcutaneous immunotherapy and sublingual immunotherapy as a tablet or drop. This study aimed to understand trends in allergy immunotherapy prescribing and practice patterns for grass allergies in adult and paediatric patients in Germany.
CSACI position statement: epinephrine auto-injectors and children less than 15 kg
Abstract (provisional)
Epinephrine (adrenaline) is the treatment of choice for anaphylaxis. While other medications, including H1-antihistamines, H2-antihistamines, corticosteroids, and inhaled beta-2 agonists are often used to treat anaphylaxis in the emergency setting, none of these medications has been shown to reverse anaphylaxis. Fatal anaphylaxis is related to the delayed use of epinephrine. In community settings, epinephrine is available as an auto-injector in two doses, 0.15 mg and 0.3 mg.
June 13, 2015
Gene-Environment Interactions in Asthma: Genetic and Epigenetic Effects
| |||||||||||||||||
|
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
- Original article
- Nicola A Hanania1,
- Michael Noonan2,
- Jonathan Corren3,
- Phillip Korenblat4,
- Yanan Zheng5,
- Saloumeh K Fischer5,
- Melissa Cheu5,
- Wendy S Putnam5,
- Elaine Murray5,
- Heleen Scheerens5,
- Cecile TJ Holweg5,
- Romeo Maciuca5,
- Sarah Gray5,
- Ramona Doyle5,
- Dana McClintock5,
- Julie Olsson5,
- John G Matthews5,
- Karl Yen5
June 11, 2015
An individualized diagnostic approach based on guidelines for chronic urticaria (CU)
- Journal of the European Academy of Dermatology and Venereology
Special Issue: An Overview of the Current Knowledge in Urticaria. Proceedings from the Global Urticaria Forum, November 2014, Prague, Czech Republic
- A.M. Giménez-Arnau1,
- C. Grattan2,
- T. Zuberbier3 and
- E. Toubi4
- AbstractChronic urticaria (CU), defined as the spontaneous or inducible appearance of hives, angioedema or both for 6 weeks or more, presents with a number of subtypes which all substantially impair patients’ quality of life (QoL).
Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment
Research
Matt J Silver12†, Noah J Kessler3†, Branwen J Hennig12, Paula Dominguez-Salas45, Eleonora Laritsky3, Maria S Baker3, Cristian Coarfa6, Hector Hernandez-Vargas7, Jovita M Castelino8, Michael N Routledge8, Yun Yun Gong9,Zdenko Herceg7, Yong Sun Lee10, Kwanbok Lee10, Sophie E Moore1112, Anthony J Fulford12, Andrew M Prentice12*and Robert A Waterland123*
Abstract
Background
Interindividual epigenetic variation that occurs systemically must be established prior to gastrulation in the very early embryo and, because it is systemic, can be assessed in easily biopsiable tissues. We employ two independent genome-wide approaches to search for such variants.
Subscribe to:
Posts (Atom)